Oric Pharmaceuticals, Inc. (ORIC) Q3 2024 Earnings
ORIC·Reported November 12, 2024·Before market open
Diluted EPS came in at $-0.49, missed the $-0.48 consensus by $0.01.
Diluted EPS
$-0.49missed by $0.01
Consensus: $-0.48
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Oric Pharmaceuticals, Inc.'s Q3 2024 earnings report.
Oric Pharmaceuticals, Inc. (ORIC) reported Q3 2024 earnings on November 12, 2024 before market open.
Oric Pharmaceuticals, Inc. reported diluted EPS of $-0.49 for Q3 2024.
EPS missed the consensus estimate of $-0.48 by $0.01.
You can read the 10-Q periodic report (0000950170-24-125471) directly on SEC EDGAR. The filing index links above go to sec.gov.